+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Enterocolitis Drug"

Necrotizing Enterocolitis - Pipeline Insight, 2024 - Product Thumbnail Image

Necrotizing Enterocolitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
Enterocolitis - Pipeline Review, H2 2019 - Product Thumbnail Image

Enterocolitis - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 54 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Enterocolitis is a type of gastrointestinal disorder that affects the small and large intestines. It is characterized by inflammation, abdominal pain, and diarrhea. Treatment for enterocolitis typically involves antibiotics, anti-inflammatory medications, and probiotics. In some cases, surgery may be necessary. The enterocolitis drug market is a subset of the larger gastrointestinal drug market. It includes medications used to treat enterocolitis, as well as other drugs used to manage symptoms associated with the disorder. These drugs are typically prescribed by gastroenterologists and other healthcare professionals. The enterocolitis drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. These companies offer a range of products, including antibiotics, anti-inflammatory medications, and probiotics. Show Less Read more